GL1X · GenesisL1 explorer

Research workbench

Structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with the thiadiazole inhibitor ipnu-107859, NMR, 1 structure

Analyse Structure of the catalytic domain of human fibroblast stromelysin-1 inhibited… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3USN
Type
protein
Length
168 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Stromelysin-1
EC
3.4.24.17
UniProt
P08254
Ligands
ATT, CA, ZN
Pockets
3 · best druggability 0.63

Structure

solution nmr · 1 distinct chain · 27% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AStromelysin-1 (EC 3.4.24.17)protein16827% helix, 12% strandP08254

Ligands and binding sites

  • ATT · 2-[3-(5-mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide · ligand · chains A
  • CA · Calcium ion · metal · 3 copies · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1970.630.8926empty
21440.590.8322empty
31920.540.7934ZN, ATT

Compared structures

  • 3USN · Structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with the… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.